课题基金 / 基金详情

CLONING of TUMOR SUPPRESSOR GENE LOCUS for ENDOMETRIAL CARCINOMA on CHROMOSOME 1

CLONING of TUMOR SUPPRESSOR GENE LOCUS for ENDOMETRIAL CARCINOMA on CHROMOSOME 1
子宫内膜癌1号染色体抑癌基因位点的克隆
批准号:
10671553
负责人:
KATO Hidenori
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

KATO Hidenori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To identify the locus of a candidate suppressor gene (s) on chr. 1, A neo-tagged human chromosome 1 that carried an interstitial q arm deletion (del-1q) or a subchromosomal transferrable fragment (30A3 STF) derived from a chr.1q was transferred into human endometrial cancer cell line, HHUA via microcell fusion. The del- 1q and the 30A2 STF had the potential to induce the growth arrest and the morphologixal changes analogous to senescent cells. These results indicate that the target gene that has senescence-inducing activity for HHUA cells is localized to the chr 1q region defined by D1S510-D1S237 or D1S103-D1S547. To further define the candidate locus, we screened 61 surgically removed endometrial cancer samples for rearrangements of deletions. Finally, we found a high incidence of LOH in the 1q41-42 region defined by the STS D1S225 and D1S459.After identifying a YAC clone, designated 748H11by Research Genetics, which keeps the both D1S225 and D1S459 markers, we transferred it into HHUA. The YAC clone could also induce the cellular senescence. By using this YAC DNA, or aBAC DNA which region is located within the YAC, several cDNA clones were isolated from the normal human endometrial cDNA library. Among them, we found one candidate which primary sequence was altered in many endometrial cancers.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
和氣徳夫: "遺伝子治療の現況と展望"日本産婦人科学会誌. 51・8. 715-724 (1999)
Norio Waki:“基因治疗的现状和前景”日本妇产科学会杂志51・8(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Zhou Y et al: "Involvement of mutations in the DPC4 promotor in endometrial carcinoma development."Molecular Carcinogenesis. 25. 64-72 (1999)
Zhou Y 等人:“DPC4 启动子突变参与子宫内膜癌的发生。”分子癌发生。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Wake,N., et al: "Involvement of IGF2 and H19 imprinting in choriocarcinoma development." International Journal of Gynecology and Obsterics. 60・1. S1-S8 (1998)
Wake, N. 等人:“IGF2 和 H19 印记在绒毛膜癌发展中的作用。”国际妇产科杂志 60·1(1998 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kato.K.,et al: "Oncogenic Ras modulates epidermal growth factor responsive ness in end ometiral carcinomas" European J.Cancer. 34・5. 737-744 (1998)
Kato.K. 等人:“致癌 Ras 调节子宫内膜癌中的表皮生长因子反应性”European J.Cancer 34·5 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    The cloning of a tumor suppressor gene against uterine endometrial cancer from the BAC clone that retains senescence-inducing ability to endomctrial cancer cell lines
    • 批准号:
      12671614
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2000
    • 负责人:
      KATO Hidenori
    • 依托单位:
    The establishment of chromosome engineering for the gene cloning
    • 批准号:
      09557132
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.06万
    • 财政年份:
      1997
    • 负责人:
      KATO Hidenori
    • 依托单位:
    子宮内膜癌抑制遺伝子の細胞老化活性を指標としたクローニング
    • 批准号:
      08671906
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.6万
    • 财政年份:
      1996
    • 负责人:
      KATO Hidenori
    • 依托单位:
    海外基金